Shenyang NovPharm Technology Co., Ltd., established in 2007, is a comprehensive pharmaceutical company specialized in the research, development, manufacturing and marketing of a broad range of APIs and high-added-value intermediates. It has independently developed intermediates of Dronedarone, Agomelatine, Perindopril and many other novel drugs, and brought them to the market successfully. The company owned independent production base which obtained ISO 9001:2000 quality system certification in 2009, with a sound quality management system. The production base occupies about 23,300 m2, located in the vicinity of Shenyang. It just accomplished total updating in 2016. After the updating, it owns fully-equipped production workshops, fine drying and packing workshop, independent warehouses for raw material and finished products respectively, R&D center, quality inspection center and sound environmental protection facilities.